We develop natural psilocybin products, medicinal formulations and treatment protocols to treat mental health disorders in a clinical environment. Psyence Therapeutics is now housed in the NASDAQ listed entity Psyence Biomedical Ltd (NASDAQ:PBM).
We operate one of the first federally licensed ISO22000 certified psilocybin cultivation and production facilities in the world.
Our range of functional mushroom wellness products harness the power of adaptogens – non-toxic, non-psychoactive plants used in ancient medicine for their stress relieving and general wellness benefits.